Clinical Trials in Portland

Showing 6561-6580 of 10,048 trials

A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen

NCT01094288

The purpose of this study is to evaluate the safety and tolerability of alisertib in combination with docetaxel as a treatment for participants with advanced solid tumors, including castration-resistant prostate cancer, who were deemed by the investigator to be medically appropriate candidates for docetaxel therapy.

Advanced Solid TumorsAdenocarcinoma of the Prostate

Millennium Pharmaceuticals, Inc.41 participantsStarted Aug 2010

Indianapolis, Indiana, United States • Portland, Oregon, United States • San Antonio, Texas, United States +1 more locations

COMPLETEDPhase 3< 1 mile

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

NCT01523587

This randomised, open-label phase III trial will be performed in patients with advanced squamous cell carcinoma of the lung requiring second-line treatment after receiving first-line platinum-based chemotherapy. The primary objective of this trial is to compare the efficacy of BIBW 2992 to erlotinib as second-line treatment in this group of patients.

Carcinoma, Non-Small-Cell Lung

Boehringer Ingelheim795 participantsStarted Mar 2012

Chandler, Arizona, United States • La Jolla, California, United States • Sacramento, California, United States +189 more locations

A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

Find Trials by Condition in Portland

Efficacy of Strength Training in Improving Elbow Range of Motion and Function in Adults With Hemophilia

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra

Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

OGX-427 in Castration Resistant Prostate Cancer Patients

Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

ESCAPE Migraine Trial

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene

CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements